This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Albert Einstein College of Medicine. Active years: 1999-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2019
Title: Innovations by Matthew D. Scharff: A Look into His Contributions to Immunology
Introduction
Matthew D. Scharff is an accomplished inventor based in Larchmont, NY, recognized for his significant contributions to the field of immunology. With a total of four patents to his name, Scharff has made strides in developing methods and peptides that advance our understanding and treatment of autoimmune diseases.
Latest Patents
Among his innovative contributions, two of Scharff's latest patents stand out. The first is titled "Methods to accelerate antibody diversification - Methods for increasing somatic hypermutation of antibodies." This invention presents techniques for enhancing the diversification of antibodies, particularly through the in vitro expression of isolated retroviral proteins in mammalian immunoglobulin-producing cells.
The second patent, "Peptides for detecting anti-double stranded DNA antibody and uses thereof," provides a method for identifying peptides that bind to anti-double stranded DNA antibodies. This invention includes a class of peptides that can specifically bind to these antibodies, paving the way for novel diagnostic and therapeutic approaches for systemic lupus erythematosus.
Career Highlights
Matthew D. Scharff is affiliated with the Albert Einstein College of Medicine, where he actively engages in research and innovation. His work is integral to advancing scientific knowledge, significantly impacting the medical field, particularly in autoimmune research.
Collaborations
Throughout his career, Scharff has collaborated with notable colleagues such as Bruce D. Gaynor and Betty A. Diamond. These partnerships have facilitated groundbreaking research, resulting in important advancements in understanding immune responses and developing related treatments.
Conclusion
In conclusion, Matthew D. Scharff's contributions to immunology through his patents and collaborative efforts exemplify the spirit of innovation in the medical field. His work continues to inspire and lead the way in developing new diagnostic and therapeutic tools that hold promise for treating complex autoimmune diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
